A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1992
12/23/1992	CA2111456A1 Recombinant immunogenic actinomycetale
12/23/1992	CA2111217A1 Insertional mutations in mycobacteria
12/23/1992	CA2111108A1 Hepatitis c diagnostics and vaccines
12/23/1992	CA2110997A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992	CA2110799A1 Microbially-produced antibody fragments and their conjugates
12/23/1992	CA2110707A1 Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
12/23/1992	CA2110495A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992	CA2110489A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands
12/22/1992	US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3
12/22/1992	US5173408 Mammalian pancreatic cholesterol esterase
12/22/1992	US5173404 Quantitative analysis; monitoring reproductive functions
12/22/1992	US5173399 Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
12/22/1992	US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen
12/22/1992	US5173293 Anti-T-cell antibodies as adjuvants
12/22/1992	CA1311703C Culture medium of bacteria (bordetella genum) containing etherified derivatives of d-glucose, and their application
12/22/1992	CA1311660C High speed automated injection system for avian embryos
12/20/1992	CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same
12/19/1992	CA2071395A1 Coccidiosis poultry vaccine
12/19/1992	CA2071305A1 Anti-hiv antibodies
12/19/1992	CA2070903A1 Process for purifying hepatitis a virus (hav), virus thus purified and vaccine compositions containing it
12/16/1992	EP0518757A1 Peptides or polypeptides of BVD and related viruses
12/16/1992	EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
12/16/1992	EP0518313A2 Gene of hepatitis C virus or fragment thereof, polypeptide encoded by the same
12/16/1992	EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
12/16/1992	EP0517853A1 METHOD FOR DETECTION OF $i(BORRELIA BURGDORFERI), PURIFIED ANTIGEN THEREOF AND ANTIBODY CAPABLE OF BINDING THEREWITH
12/16/1992	EP0517817A1 Inhibitors of catalytic antibodies
12/16/1992	EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
12/16/1992	EP0517754A1 Antibody constructs with enhanced binding affinity
12/16/1992	EP0517743A1 Improved immunogenic compositions
12/15/1992	US5171850 Intestinal oncofetal gene
12/15/1992	US5171843 Yeast-engineered amino acid sequence reactive with monoclonal antibodies against plasmodium vivex circumsprorozoite protein and useful in a vaccine preperation against maleria
12/15/1992	US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992	US5171839 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
12/15/1992	US5171685 Cloning of the Babesia bovis 60 KD antigen
12/15/1992	US5171677 Recombinant marek's disease virus and process for preparing the same
12/15/1992	US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria
12/15/1992	US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
12/15/1992	US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992	US5171568 Polypeptides are immunogenic, glycosylated and consists of glycoprotein B polypeptide and glycoprotein D or immunogenic fragments of glycoproteins
12/15/1992	US5171264 Immobilized polyethylene oxide star molecules for bioapplications
12/12/1992	WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof
12/12/1992	CA2070952A1 Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
12/10/1992	WO1992021767A1 Me20: monoclonal antibodies and antigen for human melanoma
12/10/1992	WO1992021758A1 Mycobacterium proteins and applications
12/10/1992	WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
12/10/1992	WO1992021378A1 Vaccines with erythrocytes as antigen carriers
12/10/1992	WO1992021377A1 Peptides for use in induction of t cell activation against hiv-1
12/10/1992	WO1992021376A1 Induction of ctl responses to foreign antigens expressed in mycobacteria
12/10/1992	WO1992021374A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	WO1992021370A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992019244A3 A method for treating infectious respiratory diseases
12/10/1992	WO1992017493A3 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
12/10/1992	WO1992013078A3 Pasteurella haemolytica glycoprotease gene and the purified enzyme
12/10/1992	WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
12/10/1992	DE4118155A1 Acid-stable mutants of human rhinovirus serotype 14 - used for treatment of rhino-viral infection obtd. by incubating wild type virus at varying pH cycles
12/10/1992	CA2110690A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	CA2110687A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	CA2110682A1 Induction of ctl responses to foreign antigens expressed in mycobacteria
12/10/1992	CA2110389A1 Mycobacterium proteins and applications
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/09/1992	EP0517565A2 Process for the preparation of microspheres containing biologically active components
12/09/1992	EP0517292A1 Recombinant Avipox virus
12/09/1992	EP0517024A2 Tetravalent bispecific receptors, their preparation and use
12/09/1992	EP0516953A1 Conjugates of liposomes or micro-beads and antibodies specific for T lymphocytes
12/09/1992	EP0516721A1 Antigenic proteins of plasmodium
12/09/1992	EP0516718A1 A method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function
12/09/1992	EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine.
12/09/1992	CN1019355B Process for minactivin and its use
12/08/1992	WO1992021325A1 Oral composition based on an antibiotic material and clay
12/08/1992	US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
12/08/1992	US5169940 Nucleotide sequences of protein MTP40 of M. tuberculosis
12/08/1992	US5169835 Pregancy specific proteins applications
12/08/1992	US5169784 Baculovirus dual promoter expression vector
12/08/1992	US5169763 Contains promoter for expressing non-cleavable dna fragments with signal peptide in mammalian cells
12/08/1992	US5169752 Methods and materials for HIV detection
12/08/1992	US5169628 Vaccines
12/08/1992	US5169627 Having resistance to degradation by intestinal enzymes while retaining immunological activity
12/08/1992	CA2088983A1 Therapeutic composition for gastrointestinal system inflammations
12/07/1992	WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof
12/07/1992	WO1992021375A1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
12/07/1992	CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications
12/04/1992	CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof
12/02/1992	EP0516396A1 Eimeria acervulina dna probes
12/02/1992	EP0516395A2 Eimeria necatrix dna probes
12/02/1992	EP0516391A2 Eimeria brunetti dna probes
12/02/1992	EP0516386A1 Eimeria mitis DNA probes
12/02/1992	EP0516385A1 Eimeria tenella DNA probes
12/02/1992	EP0516384A1 Eimeria praecox DNA probes
12/02/1992	EP0516383A2 Eimeria maxima dna probes
12/02/1992	EP0516287A2 Human rotavirus of serotype 3 HCR3A, reassortants thereof and vaccine compositions containing them
12/02/1992	EP0516286A1 Hepatitis B virus surface proteins with reduced host carbohydrate content
12/02/1992	EP0516190A2 Monoclonal antibodies, process for preparing them and their use
12/02/1992	EP0516135A2 Human immunodeficiency virus-related immune preparation
12/02/1992	CN1019267B Synthetic vaccines for foot and mounth disease
12/01/1992	WO1992021755A1 Treatment of hiv-associated immune thrombocytopenic purpura

1 ... 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 ... 1823